Beam Therapeutics Inc.

BEAM · Healthcare · · USD

35.82 USD

+0.00 (0.00%)

● Updated 2026-07-10 18:11 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Short-term (Swing)

/ 100

Technical 75

Trend & RS 96

Momentum 58

Fundamental (0%) 67

Macro 65

Liquidity 44

Component	Score	Weight
Technical	75.0	40%
Trend & RS	95.6	20%
Momentum	58.4	20%
Fundamental	66.7	0%
Macro	65.2	15%
Liquidity	43.8	5%

Trade Setup

Entry	32.09
Stop Loss	26.75 (16.6%)
Target 1 (1:1)	37.44 (+16.6%)
Target 2 (2:1)	42.77 (+33.3%)

ATR(14)	2.67 (8.3%)
Risk per Share	5.34
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	73.1	+0.92
Momentum	58.4	+0.33
Quality	36.2	-0.55
Composite	55.9

Quality Scores

Piotroski F-Score 3 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 7.66 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	3.1	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

47.4%

Full Kelly

23.7%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 73/100. Estimated win rate 62%, avg win 9.4%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

46.39

RSI(14)

1.1781

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↑ RISING (+11.0% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (3d since high)
Sector Outperformance	+16.5% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	46.39	NEUTRAL
Macd	1.1781	BEARISH
Ma Cross	31.56 / 27.93	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.36x	LOW

Key Levels

Level	Price
52-Week High	38.26
Bollinger Upper	38.33
SMA(200)	27.93
SMA(50)	31.56
SMA(20)	33.71
Current Price	35.82
Bollinger Lower	29.08
52-Week Low	15.60
ATR(14)	2.67

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION E Confidence

50%

Acc: 1.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	0.92x	Normal bar — no special VSA pattern
2026-07-07	Normal	1.51x	Normal bar — no special VSA pattern
2026-07-08	Normal	1.5x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.96x	Normal bar — no special VSA pattern
2026-07-10	Normal	0.36x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	35.14	Above Kijun
Kijun-sen (26)	33.28	Base line
Senkou A	34.21	Leading span A
Senkou B	32.06	Leading span B
Cloud	32.06 – 34.21	Bullish (Green)
Price vs Cloud	32.09	Inside Cloud
Chikou Span	29.55	Bullish
Alignment Score	3/4	NEUTRAL